SEC Form 4 · accession 0001615774-16-004862
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George C Carpenter IV
Officer — Chief Executive Officer
Period of report
Apr 5, 2016
Accepted (ET)
Apr 7, 2016 · 9:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 5, 2016 | A | 1,000,000 | $0.00 | A | 2,390,799 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares are held in the name of George and Jill Carpenter.